Our Technology
A precision biological platform powered by the world's most comprehensive bacteriophage bio-bank
The Bio-Bank
Our crown jewel — one of the world's largest bacteriophage libraries
Each strain precisely characterized and catalogued for targeted pathogen matching.
The broadest reference collection for real-world agricultural pathogen threats.
New strains isolated and added as field samples reveal emerging bacterial threats.
The Data Flywheel
Continuous improvement driven by real-world intelligence
Collect
16,000+ real-world field pathogen samples collected annually from farms across the globe.
Analyze
Proprietary bioinformatics platform processes 12,000+ phage genomes to match optimal phage-pathogen pairings.
Iterate
Formulations updated every 30–90 days to stay ahead of evolving bacterial strains — not years, days.
Multi-Phage Cocktails
Defeating resistance at the molecular level
Every iPhage™ product deploys 2–3 distinct bacteriophages per target bacterial strain. For a bacterium to survive, it would need to develop simultaneous resistance to all phages in the cocktail.
This multi-phage approach is what sets biological pathogen control apart from conventional antibiotics, where single-target resistance emerges rapidly. With iPhage™, efficacy is maintained over time, not eroded.
Conventional Antibiotics
Single target → rapid resistance
iPhage™ Cocktails
Multi-target → sustained efficacy
Proactive Closed-Loop System
New-Line Biotech & Genesis Biosciences Core Philosophy & Success Principles
“A single trial outcome—whether positive or negative—is never the whole story. Field results are often influenced by complex environmental factors and farm management variables beyond target pathogen isolate control.
At New-Line & Genesis, the key to long-term disease control lies in building a proactive, closed-loop system: continuous disease sampling, ongoing epidemiological surveillance, dynamic phage screening, and timely product formulation upgrades.”
Disease Sampling
Continuous collection of real-world pathogen isolates directly from affected farming environments.
Epidemiological Surveillance
Ongoing monitoring and genetic tracking of dominant circulating strains to detect pathogen shifts early.
Phage Screening
Rapid high-throughput screening against our 6,000+ phage strain library to select targeted 2–3 phage cocktails.
Product Formulation Upgrades
Dynamic formulation updates delivered every 30–90 days to ensure iPhage™ efficacy stays ahead of bacterial mutations.
Formulation Stability
Engineered for the harshest real-world conditions
Micro-Coating Technology
Proprietary encapsulation protects active phages through processing, storage, and the digestive tract.
Thermal Resilience
Withstands feed pelleting temperatures of 85–90°C — no loss of potency during feed production.
pH Range
Active across the full digestive pH range of 3–9, ensuring efficacy from crop to intestine.
Manufacturing & Quality
Pharmaceutical-grade standards at industrial scale